Bendamustine lymphodepletion before axicabtagene ciloleucel is safe and associates with reduced inflammatory cytokinesGuido Ghilardi, Marco Ruella, Ivan Cohen et al.|Blood Advances|2023Cited by 30
CAR T-Cell Immunotherapy in Minority Patients with LymphomaGuido Ghilardi, Marco Ruella, Staci Williamson et al.|NEJM Evidence|2024Cited by 20
Efficacy and safety of bendamustine for lymphodepletion before lisocabtagene maraleucelGuido Ghilardi, Marco Ruella, Luca Paruzzo et al.|Journal of Hematology & Oncology|2024Cited by 8